TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer

Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer. TYMS encodes thymidylate synthase, which is important for DNA synthesis. The TYMS gene has been assessed in some tumors. However, the specifi...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) Vol. 98; no. 51; p. e18487
Main Authors: Fu, Zhuo, Jiao, Yan, Li, Yanqing, Ji, Bai, Jia, Baoxing, Liu, Bin
Format: Journal Article
Language:English
Published: United States Wolters Kluwer Health 01.12.2019
Subjects:
ISSN:0025-7974, 1536-5964, 1536-5964
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer. TYMS encodes thymidylate synthase, which is important for DNA synthesis. The TYMS gene has been assessed in some tumors. However, the specific role of TYMS in pancreatic cancer has not been identified. This study was designed to clarify the diagnostic and prognostic significance of TYMS in pancreatic cancer.The Cancer Genome Atlas (TCGA) database was used to compare TYMS expression in pancreatic cancer, and ROC curve analysis was used to investigate its diagnostic value. The correlation between clinical characteristics and TYMS expression was analyzed, and the prognostic value of TYMS expression in the patients with pancreatic cancer was assessed by Kaplan-Meier curves and Cox analysis.TYMS was upregulated in pancreatic cancer and associated with poor overall survival (OS) and recurrence-free survival (RFS). Univariate and multivariate survival analysis demonstrated that TYMS is an independent risk factor for OS and RFS in patients with pancreatic cancer.The upregulation of TYMS in pancreatic cancer leads to unfavorable OS and RFS in patients, and represents a diagnostic and prognostic biomarker for patients with pancreatic cancer.
AbstractList Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer. TYMS encodes thymidylate synthase, which is important for DNA synthesis. The TYMS gene has been assessed in some tumors. However, the specific role of TYMS in pancreatic cancer has not been identified. This study was designed to clarify the diagnostic and prognostic significance of TYMS in pancreatic cancer.The Cancer Genome Atlas (TCGA) database was used to compare TYMS expression in pancreatic cancer, and ROC curve analysis was used to investigate its diagnostic value. The correlation between clinical characteristics and TYMS expression was analyzed, and the prognostic value of TYMS expression in the patients with pancreatic cancer was assessed by Kaplan-Meier curves and Cox analysis.TYMS was upregulated in pancreatic cancer and associated with poor overall survival (OS) and recurrence-free survival (RFS). Univariate and multivariate survival analysis demonstrated that TYMS is an independent risk factor for OS and RFS in patients with pancreatic cancer.The upregulation of TYMS in pancreatic cancer leads to unfavorable OS and RFS in patients, and represents a diagnostic and prognostic biomarker for patients with pancreatic cancer.Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer. TYMS encodes thymidylate synthase, which is important for DNA synthesis. The TYMS gene has been assessed in some tumors. However, the specific role of TYMS in pancreatic cancer has not been identified. This study was designed to clarify the diagnostic and prognostic significance of TYMS in pancreatic cancer.The Cancer Genome Atlas (TCGA) database was used to compare TYMS expression in pancreatic cancer, and ROC curve analysis was used to investigate its diagnostic value. The correlation between clinical characteristics and TYMS expression was analyzed, and the prognostic value of TYMS expression in the patients with pancreatic cancer was assessed by Kaplan-Meier curves and Cox analysis.TYMS was upregulated in pancreatic cancer and associated with poor overall survival (OS) and recurrence-free survival (RFS). Univariate and multivariate survival analysis demonstrated that TYMS is an independent risk factor for OS and RFS in patients with pancreatic cancer.The upregulation of TYMS in pancreatic cancer leads to unfavorable OS and RFS in patients, and represents a diagnostic and prognostic biomarker for patients with pancreatic cancer.
Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer. TYMS encodes thymidylate synthase, which is important for DNA synthesis. The TYMS gene has been assessed in some tumors. However, the specific role of TYMS in pancreatic cancer has not been identified. This study was designed to clarify the diagnostic and prognostic significance of TYMS in pancreatic cancer. The Cancer Genome Atlas (TCGA) database was used to compare TYMS expression in pancreatic cancer, and ROC curve analysis was used to investigate its diagnostic value. The correlation between clinical characteristics and TYMS expression was analyzed, and the prognostic value of TYMS expression in the patients with pancreatic cancer was assessed by Kaplan–Meier curves and Cox analysis. TYMS was upregulated in pancreatic cancer and associated with poor overall survival (OS) and recurrence-free survival (RFS). Univariate and multivariate survival analysis demonstrated that TYMS is an independent risk factor for OS and RFS in patients with pancreatic cancer. The upregulation of TYMS in pancreatic cancer leads to unfavorable OS and RFS in patients, and represents a diagnostic and prognostic biomarker for patients with pancreatic cancer.
Author Jiao, Yan
Liu, Bin
Ji, Bai
Fu, Zhuo
Jia, Baoxing
Li, Yanqing
AuthorAffiliation b Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University
c Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, PR China
a Department of Hand and Foot Surgery, The First Hospital of Jilin University
AuthorAffiliation_xml – name: b Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University
– name: a Department of Hand and Foot Surgery, The First Hospital of Jilin University
– name: c Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, PR China
Author_xml – sequence: 1
  givenname: Zhuo
  surname: Fu
  fullname: Fu, Zhuo
  organization: Department of Hand and Foot Surgery, The First Hospital of Jilin University
– sequence: 2
  givenname: Yan
  surname: Jiao
  fullname: Jiao, Yan
  organization: Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University
– sequence: 3
  givenname: Yanqing
  surname: Li
  fullname: Li, Yanqing
  organization: Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, PR China
– sequence: 4
  givenname: Bai
  surname: Ji
  fullname: Ji, Bai
  organization: Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University
– sequence: 5
  givenname: Baoxing
  surname: Jia
  fullname: Jia, Baoxing
  organization: Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University
– sequence: 6
  givenname: Bin
  surname: Liu
  fullname: Liu, Bin
  organization: Department of Hand and Foot Surgery, The First Hospital of Jilin University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31861032$$D View this record in MEDLINE/PubMed
BookMark eNp9UctOGzEUtRAVJLRfgIRmyWaCX-OxN5UqHi0SUReli25qeTx3gmFiB3sS1L-vQ8JzgTf29T0P-9wx2vXBA0KHBE8IVvXJ9GyCXxaRXNY7aEQqJspKCb6LRhjTqqxVzffROKXbDGI15XtonxEpCGZ0hP5e_5n-KhYREvghFabwYQV90bgwN_EOYtGFWLTOzHxILvd9m8FhWzlfLMzgHpkPbrjJlbcR8pUtbD5C_Iw-daZP8GW7H6DfF-fXpz_Kq5_fL0-_XZWW42oojVUWY4ulwaLjrGLWcEI6KUA20lAmaAeiY1jWwrZS2YoaMA0D1TaYc9qxA_R1o7tYNnNobX5SNL1eRJe_8U8H4_Tbjnc3ehZWWiieo6NZ4HgrEMP9EtKg5y5Z6HvjISyTpoyqmomKsQw9eu31bPIUagaoDcDGkFKETls35FDC2tr1mmC9HqCenun3A8xc9o77JP8R6z9W_56-
CitedBy_id crossref_primary_10_3389_fphar_2022_1070948
crossref_primary_10_1097_MD_0000000000025344
crossref_primary_10_3389_fgene_2020_614195
crossref_primary_10_1002_jcp_31033
crossref_primary_10_2147_CMAR_S304719
crossref_primary_10_1002_ctm2_1550
crossref_primary_10_3390_healthcare10010155
crossref_primary_10_3390_biomedicines10061267
crossref_primary_10_3389_fmed_2025_1510431
crossref_primary_10_4014_jmb_2310_10052
crossref_primary_10_2147_OTT_S275649
crossref_primary_10_3389_fimmu_2025_1600863
crossref_primary_10_3389_fonc_2021_801173
crossref_primary_10_3748_wjg_v27_i35_5851
crossref_primary_10_3390_cancers16213684
crossref_primary_10_3390_ani12182463
crossref_primary_10_1158_1078_0432_CCR_23_0825
crossref_primary_10_3389_fgene_2021_775006
crossref_primary_10_3390_cancers15205003
crossref_primary_10_3389_fgene_2021_682237
crossref_primary_10_3389_fmolb_2022_1034208
crossref_primary_10_1016_j_ctarc_2024_100862
crossref_primary_10_1177_1533033820980112
crossref_primary_10_1016_j_jbc_2023_105457
crossref_primary_10_3390_jpm13060985
crossref_primary_10_1016_j_ygeno_2022_110425
crossref_primary_10_1039_D2FO01737G
Cites_doi 10.1016/S0092-8674(00)81683-9
10.3748/wjg.v22.i44.9694
10.1371/journal.pone.0211291
10.1002/ijc.29495
10.18632/oncotarget.3107
10.1146/annurev.bi.64.070195.003445
10.2147/CMAR.S185459
10.3892/mmr.2014.3141
10.18388/abp.2017_2338
10.1186/1471-2105-12-77
10.3892/etm.2015.2636
10.1371/journal.pone.0106397
10.3748/wjg.v24.i19.2047
10.3892/ol.2017.5895
10.1111/bju.14200
10.1016/S0140-6736(16)00141-0
10.1002/prca.201500138
10.18632/oncotarget.20774
ContentType Journal Article
Copyright Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019
Copyright_xml – notice: Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000018487
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
ExternalDocumentID PMC6940182
31861032
10_1097_MD_0000000000018487
Genre Journal Article
Observational Study
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
1CY
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
AAYXX
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACBKD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADFPA
ADGGA
ADHPY
ADKSD
ADNKB
ADPDF
ADSXY
AE3
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGOPY
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
BS7
BYPQX
CITATION
CS3
DIWNM
DU5
E.X
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
FW0
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB2
OCUKA
ODA
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWU
OWV
OWW
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
RPM
RXW
S4R
S4S
T8P
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
ZFV
ZGI
ZXP
ZY1
ADGHP
CGR
CUY
CVF
ECM
EIF
NPM
TAF
7X8
5PM
ID FETCH-LOGICAL-c405t-ac9c00c08a06f4353ca411f86e8b8a2362fe6f30876cd89c52aeab3e9db0442f3
ISICitedReferencesCount 37
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000511458900090&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0025-7974
1536-5964
IngestDate Tue Nov 04 02:03:23 EST 2025
Sun Sep 28 08:23:38 EDT 2025
Thu Jul 10 08:32:30 EDT 2025
Sat Nov 29 05:34:16 EST 2025
Tue Nov 18 21:09:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 51
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c405t-ac9c00c08a06f4353ca411f86e8b8a2362fe6f30876cd89c52aeab3e9db0442f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000018487
PMID 31861032
PQID 2329736533
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6940182
proquest_miscellaneous_2329736533
pubmed_primary_31861032
crossref_citationtrail_10_1097_MD_0000000000018487
crossref_primary_10_1097_MD_0000000000018487
PublicationCentury 2000
PublicationDate 2019-12-01
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2019
Publisher Wolters Kluwer Health
Publisher_xml – name: Wolters Kluwer Health
References Samur (R8-20230915) 2014; 9
Gallegos-Arreola (R4-20230915) 2018; 65
Jiao (R12-20230915) 2018; 10
Xu (R17-20230915) 2017; 13
(R7-20230915) 2012; 1
Therneau (R11-20230915) 2000; 97
Jiang (R18-20230915) 2015; 11
Kamisawa (R21-20230915) 2016; 388
Burdelski (R6-20230915) 2015; 6
Jiao (R13-20230915) 2019; 14
Yeh (R20-20230915) 2017; 8
Abdallah (R19-20230915) 2015; 137
Sun (R15-20230915) 2015; 10
Russo (R16-20230915) 2018; 122
Robin (R9-20230915) 2011; 12
Gupta (R14-20230915) 2016; 10
Ilic (R1-20230915) 2016; 22
Zhang (R2-20230915) 2018; 24
Hanahan (R3-20230915) 2000; 100
Carreras (R5-20230915) 1995; 64
References_xml – volume: 100
  start-page: 57
  year: 2000
  ident: R3-20230915
  article-title: The hallmark of cancer
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81683-9
– volume: 22
  start-page: 9694
  year: 2016
  ident: R1-20230915
  article-title: Epidemiology of pancreatic cancer
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i44.9694
– volume: 14
  start-page: e0211291
  year: 2019
  ident: R13-20230915
  article-title: Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0211291
– volume: 137
  start-page: 1397
  year: 2015
  ident: R19-20230915
  article-title: Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients
  publication-title: Int J Cancer
  doi: 10.1002/ijc.29495
– volume: 6
  start-page: 8377
  year: 2015
  ident: R6-20230915
  article-title: Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3107
– volume: 64
  start-page: 721
  year: 1995
  ident: R5-20230915
  article-title: The catalytic mechanism and structure of thymidylate synthase
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.bi.64.070195.003445
– volume: 10
  start-page: 6003
  year: 2018
  ident: R12-20230915
  article-title: High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S185459
– volume: 11
  start-page: 3523
  year: 2015
  ident: R18-20230915
  article-title: Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2014.3141
– volume: 65
  start-page: 227
  year: 2018
  ident: R4-20230915
  article-title: TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients
  publication-title: Acta Biochim Pol
  doi: 10.18388/abp.2017_2338
– volume: 12
  start-page: 1
  year: 2011
  ident: R9-20230915
  article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves
  publication-title: Bmc Bioinformatics
  doi: 10.1186/1471-2105-12-77
– volume: 10
  start-page: 937
  year: 2015
  ident: R15-20230915
  article-title: Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2015.2636
– volume: 1
  start-page: 12
  year: 2012
  ident: R7-20230915
  article-title: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
  publication-title: Computing
– volume: 9
  start-page: e106397
  year: 2014
  ident: R8-20230915
  article-title: RTCGAToolbox: a new tool for exporting TCGA firehose data
  publication-title: Plos One
  doi: 10.1371/journal.pone.0106397
– volume: 24
  start-page: 2047
  year: 2018
  ident: R2-20230915
  article-title: Challenges in diagnosis of pancreatic cancer
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i19.2047
– volume: 13
  start-page: 3387
  year: 2017
  ident: R17-20230915
  article-title: MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase
  publication-title: Oncol Lett
  doi: 10.3892/ol.2017.5895
– volume: 97
  start-page: 353
  year: 2000
  ident: R11-20230915
  article-title: Modeling survival data: extending the cox model
  publication-title: Technometrics
– volume: 122
  start-page: 152
  year: 2018
  ident: R16-20230915
  article-title: Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer
  publication-title: BJU Int
  doi: 10.1111/bju.14200
– volume: 388
  start-page: 73
  year: 2016
  ident: R21-20230915
  article-title: Pancreatic cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00141-0
– volume: 10
  start-page: 564
  year: 2016
  ident: R14-20230915
  article-title: Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients
  publication-title: Proteomics Clin Appl
  doi: 10.1002/prca.201500138
– volume: 8
  start-page: 77734
  year: 2017
  ident: R20-20230915
  article-title: Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20774
SSID ssj0013724
Score 2.4588506
Snippet Pancreatic cancer is one of the most malignant tumors worldwide. DNA replication plays a critical role in the occurrence and development of pancreatic cancer....
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e18487
SubjectTerms Biomarkers, Tumor - metabolism
Case-Control Studies
China - epidemiology
Female
Humans
Male
Middle Aged
Observational Study
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - mortality
Prognosis
Thymidylate Synthase - metabolism
Up-Regulation
Title TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/31861032
https://www.proquest.com/docview/2329736533
https://pubmed.ncbi.nlm.nih.gov/PMC6940182
Volume 98
WOSCitedRecordID wos000511458900090&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 20241231
  omitProxy: false
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lBSEuiDcpUC0St2Bw7I139wiUigOtOBSUXrDWm7VqKVqHvNT_0D_N7DNOiip6IAcrcTYbJ_N5dmZn5huE3uZMEtsjjFU0M6TaLKlYKhJVTwSnhi_Ekvr8_EZPT9l4zL_3elehFmY9pVqzy0s--6-ihnMgbFM6ewtxx0nhBDwHocMRxA7HfxP8OfjmM1dVtBiIgW7XajowZfYmE2du8wonLsGuWXiegNa_2hCt-qo30BXOrJQmPUz6VN7QAcrH5Y2V-klMl41L2o1bC8crG_q4WLUxT6cRdmv2vJMJ1PgTv8Miase5WEjT3ZQY8k6CRygSMEyYrgHPexV0a5GMuCMtD8qXsw7IPPWsU6UKfE-3Fl_T8o49-OTIkU-6Rxy9zam9s9bFDMQQez85Kncn2UN3MkApC_55CEnRjMT-v_DLAoUVpx_-ciXbZs4132U3Bbdj05w9RA-8M4I_OhA9Qj2lH6N7QaxP0C-DJRywhAW2WMIRSxiwhCOWMGAJRyzhRuOAJWywhDdYwg5LT9GP4y9nn78mviFHAjf0aJkIyWWaypSJtKjBzs6lIMNhzQrFKiYysIVqVdSGY7KQE8blKBNKVLnikyolJKvzZ2hft1q9QDivwDStwFcGj4PkhFRgJkkhzXpT13k17KMs_H-l9Gz1pmnKtLxBcn30Ln5o5shabh7-JgimBKVqImVCq3a1KMHN4DQvwBXqo-dOUHFCWAQLw0LZR3RLhHGAIWzffkc3F5a4veAEvjk7uN1lvkT3N7fYK7S_nK_Ua3RXrpfNYn6I9uiYHVqo_gHAMa6F
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TYMS+presents+a+novel+biomarker+for+diagnosis+and+prognosis+in+patients+with+pancreatic+cancer&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Fu%2C+Zhuo&rft.au=Jiao%2C+Yan&rft.au=Li%2C+Yanqing&rft.au=Ji%2C+Bai&rft.date=2019-12-01&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=98&rft.issue=51&rft.spage=e18487&rft_id=info:doi/10.1097%2FMD.0000000000018487&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_MD_0000000000018487
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon